Adenocarcinoma
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Furthermore, expression of Notch1 and its effector Hey-1 gene in human prostate adenocarcinomas were found significantly down-regulated compared to normal control tissues.
|
16360140 |
2006 |
Adenocarcinoma of prostate
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Reduced Hey-1 expression was seen in tumor foci but not in benign tissue, confirming loss of Notch-1 signaling in prostate adenocarcinoma.
|
19479935 |
2009 |
Adult Glioblastoma
|
0.030 |
PosttranslationalModification
|
disease |
BEFREE |
Methylation regulates HEY1 expression in glioblastoma.
|
28574840 |
2017 |
Adult Glioblastoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Nuclear Factor I Represses the Notch Effector HEY1 in Glioblastoma.
|
30195713 |
2018 |
Adult Glioblastoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
Together, these data imply a role for HEY1 in the progression of GBM, and therefore we propose that HEY1 may be a therapeutic target for glioblastoma patients.
|
18363832 |
2009 |
Adult Oligodendroglioma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Inhibition of notch signaling blocks growth of glioblastoma cell lines and tumor neurospheres.
|
21127729 |
2010 |
Adult Rhabdomyosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The efficacy of Notch pathway inhibition in vivo supports the development of Notch-Hey1 axis inhibitors in the treatment of eRMS.
|
21948088 |
2011 |
Alveolar rhabdomyosarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The expression of GREM1, DAPK1 and MYOD1 were significantly upregulated; HEY1 was significantly downregulated in independent P3F-positive ARMS tumors and transcriptionally active P3F cells, compared to those in ERMS tumors and transcriptionally inactive P3F cells.
|
23733015 |
2013 |
Anaplastic astrocytoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Inhibition of notch signaling blocks growth of glioblastoma cell lines and tumor neurospheres.
|
21127729 |
2010 |
Anaplastic Oligodendroglioma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Inhibition of notch signaling blocks growth of glioblastoma cell lines and tumor neurospheres.
|
21127729 |
2010 |
Aortic Valve Insufficiency
|
0.010 |
Biomarker
|
disease |
BEFREE |
We previously reported that HEY1 and HEY2 selectively repress androgen receptor (AR) signaling in mammalian cell lines and have shown that in human tissue HEY1 is excluded from the nuclei in prostate cancer but not benign prostatic hyperplasia.
|
21454491 |
2011 |
Astrocytoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Inhibition of notch signaling blocks growth of glioblastoma cell lines and tumor neurospheres.
|
21127729 |
2010 |
Autism Spectrum Disorders
|
0.300 |
Biomarker
|
disease |
CTD_human |
Our analysis identified several novel dysregulated genes and miRNAs in ASD compared with controls, including HEY1, SOX9, miR-486 and miR-181b.
|
20868653 |
2011 |
B-Cell Lymphomas
|
0.010 |
AlteredExpression
|
group |
BEFREE |
We also demonstrate that Hey1 and TrkC-KF transcriptionally silence mouse double minute 2 homolog (MDM2), thus contributing to p53 stabilization. p53 transcriptionally regulates the expression of TrkC-KF cytoplasmic and mitochondrial interactors cofactor of breast cancer 1 (COBRA1) and B cell lymphoma 2-associated X (BAX), which will subsequently trigger the intrinsic pathway of apoptosis.
|
29750782 |
2018 |
Benign Prostatic Hyperplasia
|
0.010 |
Biomarker
|
disease |
BEFREE |
We previously reported that HEY1 and HEY2 selectively repress androgen receptor (AR) signaling in mammalian cell lines and have shown that in human tissue HEY1 is excluded from the nuclei in prostate cancer but not benign prostatic hyperplasia.
|
21454491 |
2011 |
Breast Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation.
|
21036696 |
2010 |
Carcinogenesis
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Inhibition of the Notch-Hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesis.
|
21948088 |
2011 |
Carcinogenesis
|
0.020 |
AlteredExpression
|
phenotype |
BEFREE |
Overexpression of HEY1 and HEY2 in ESCC is correlated to different indices of poor prognosis and it is extrapolated that such overexpression is important in progression and development of ESCC tumorigenesis.
|
25361534 |
2015 |
Carcinoma of lung
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In this study, we showed that a high percentage of lung cancer lines expressed Jagged1, Notch receptors, and their transcriptional target genes (HES1, Hey1), suggesting that the Notch pathway plays an important role in lung cancer biology.
|
17804716 |
2007 |
Carcinoma, Pancreatic Ductal
|
0.300 |
Biomarker
|
disease |
CTD_human |
Inhibition of gamma-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma.
|
19208345 |
2009 |
Central neuroblastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Of interest, TrkC was proposed to constrain tumor progression in neuroblastoma (NB), and we demonstrate in an avian model that TrkC tumor suppressor activity requires Hey1 and p53.
|
29750782 |
2018 |
Cerebral Astrocytoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Inhibition of notch signaling blocks growth of glioblastoma cell lines and tumor neurospheres.
|
21127729 |
2010 |
Cerebral Primitive Neuroectodermal Tumor
|
0.300 |
Biomarker
|
disease |
CTD_human |
Inhibition of notch signaling blocks growth of glioblastoma cell lines and tumor neurospheres.
|
21127729 |
2010 |
Childhood Cerebral Astrocytoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Inhibition of notch signaling blocks growth of glioblastoma cell lines and tumor neurospheres.
|
21127729 |
2010 |
Childhood Embryonal Rhabdomyosarcoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Inhibition of the Notch-Hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesis.
|
21948088 |
2011 |